Post by
Guytorule on Oct 31, 2024 7:50pm
New debenture raise..to replace current debenture..!
Good news, just released new debenture raise to replace current outstanding debenture due. Conversion possible within 1 year at a share price of .05 cents. All good, and with other good news today with their sustainability result of their Sairiyo drug thats entering approved FDA clinical trial shortly, only brings heighten value to shareholders with raising share price...At .02/ share is a screaming buy currently and may definately be a multi-bagger return to investors. Risk/Reward high. Accumulating at this current share price bottom is an opportunity, in my opinion. Good luck to everyone holding and accumulating share...
Comment by
Tommyjohn on Oct 31, 2024 9:30pm
Yes, does seem like good news, but are they not still short on cash. Still can't figure out the spike a few months back, just to fall flat. Is there no short terms catalysts in the works? I thought with that spike we would have seen something substantial by now.
Comment by
Tommyjohn on Nov 01, 2024 12:10am
Wow, great information, I really appreciate the insight.